Texas invests $50M in psychedelic drug research to treat addiction
Medical Xpress
JUNE 16, 2025
The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. Food and Drug Administration (FDA). The process could take years. Ibogaine is made from the root of a plant found in Africa. It has been banned in the U.S. Former Texas Gov.
52 
Let's personalize your content